ORLive Presents: Access to Surgical Intervention for Metabolic Syndrome and Other Diseases
Posted on: Monday, 16 June 2008, 12:01 CDT
On Tuesday, June 17, 2008, at 4:00 pm CDT, ORLive.com will broadcast a panel discussion entitled, "Access to Surgical Intervention for Metabolic Syndrome and Other Diseases." Dr. Henry Buchwald, Professor of Surgery, University of Minnesota, Minneapolis, Minnesota, will serve as moderator. The panel will include Dr. Neil Hutcher, Commonwealth Surgeons, St Mary's Bon Secours Hospital, Richmond, VA., Dr. Scott A. Shikora, Professor of Surgery, Tufts University School of Medicine, Chief, General, Bariatric and Minimally Invasive Surgery, Tufts Medical Center, Boston, Massachusetts, and Walter Lindstrom, Jr., Esq., Obesity Law and Advocacy Center, Chula Vista, CA., a leading advocate for the rights of persons suffering from obesity. Join this leadership panel as they discuss the challenges of access to surgical intervention for the resolution of metabolic syndrome and other diseases and suggestions for improvement.
Questions from Healthcare professionals and the general public can be sent to Dr. Buchwald, Dr. Hutcher, Dr. Shikora, and Mr. Lindstrom up to seven days following the broadcast. The panelists will also address questions on June 18, 2008 at the American Society for Metabolic and Bariatric Surgery Annual meeting in Washington, D.C.
Obesity is associated with multiple co-morbidities, including diabetes mellitus, hypertension, hypercholesterolemia, obstructive sleep apnea, osteoarthritis, gastroesophageal reflux disease (GERD), asthma, and depression. These co-morbidities are responsible for more than 2.5 million deaths per year worldwide. Surgical weight loss has been shown to improve if not resolve many of these co-morbidities.
About Synovis Life Technologies
Synovis Life Technologies, Inc. (NASDAQ: SYNO), based in St. Paul, Minn., is a diversified medical device company engaged in developing, manufacturing, and bringing to market medical devices for the surgical and interventional treatment of disease.
To learn more and view a program preview visit OR-Live
VNR: OR-Live.com
Video-Link Available: http://www2.marketwire.com/mw/frame_mw?attachid=780273
Contact: Alex Fraser Direct of Marketing OR-Live 860 953 2900 x214 Email Contact
SOURCE: OR-Live, Inc.
Source: MARKET WIRE
Related Articles
- Drinking 100 Percent Fruit Juice Is Linked With Lower Risk Of Obesity And Metabolic Syndrome
- Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., As Senior Vice President, Head of Obesity and Metabolic Disorders
- GI Dynamics to Present Data From Clinical Weight Loss Study of EndoBarrier(TM) Gastrointestinal Liner in Morbidly Obese Patients at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress
- Patients With Bypass Surgery Live Longer
- The Legal Trap in Surgical Medical Releases
- Adipocyte Fatty Acid-Binding Protein Is a Plasma Biomarker Closely Associated With Obesity and Metabolic Syndrome
- HealthEast Performs Surgery Live on Internet
- ABAXIS Launches 'Basic Metabolic Panel Plus' for the Oncology Market
- Research and Markets: Business Opportunities in Diabetes, Obesity and Metabolic Disease Market Analysed
- Medicare Advisory Panel Concludes Weight Loss Surgery Safe and Effective for Morbidly Obese Patients
 |
 |
User Comments (0)
RSS Feeds